Adage Capital Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-42,531
| Closed | -$11.6M | – | 994 |
|
|
2025
Q3 | $11.6M | Buy |
42,531
+40,432
| +1,926% | +$11M | 0.02% | 604 |
|
|
2025
Q2 | $542K | Sell |
2,099
-22,564
| -91% | -$5.38M | ﹤0.01% | 807 |
|
|
2025
Q1 | $5.52M | Sell |
24,663
-21,876
| -47% | -$5.11M | 0.01% | 684 |
|
|
2024
Q4 | $10.6M | Buy |
46,539
+35,103
| +307% | +$8.45M | 0.02% | 587 |
|
|
2024
Q3 | $2.79M | Buy |
+11,436
| New | +$2.56M | ﹤0.01% | 764 |
|
|
2024
Q1 | – | Sell |
-142,884
| Closed | -$24.6M | – | 939 |
|
|
2023
Q4 | $24.6M | Buy |
142,884
+66,442
| +87% | +$10.2M | 0.05% | 367 |
|
|
2023
Q3 | $11.3M | Sell |
76,442
-119,942
| -61% | -$21.7M | 0.03% | 535 |
|
|
2023
Q2 | $42.9M | Buy |
196,384
+49,300
| +34% | +$11M | 0.09% | 219 |
|
|
2023
Q1 | $32.2M | Sell |
147,084
-1,900
| -1% | -$412K | 0.07% | 309 |
|
|
2022
Q4 | $31M | Sell |
148,984
-200
| -0.1% | -$43.9K | 0.07% | 311 |
|
|
2022
Q3 | $32.6M | Sell |
149,184
-3,200
| -2% | -$728K | 0.08% | 268 |
|
|
2022
Q2 | $31.9M | Sell |
152,384
-300
| -0.2% | -$63.9K | 0.07% | 285 |
|
|
2022
Q1 | $37M | Sell |
152,684
-2,600
| -2% | -$629K | 0.07% | 295 |
|
|
2021
Q4 | $40.4M | Buy |
155,284
+45,115
| +41% | +$11.7M | 0.07% | 277 |
|
|
2021
Q3 | $29M | Sell |
110,169
-47,200
| -30% | -$12.9M | 0.06% | 342 |
|
|
2021
Q2 | $38.8M | Buy |
157,369
+36,200
| +30% | +$7.61M | 0.08% | 269 |
|
|
2021
Q1 | $23.5M | Sell |
121,169
-38,600
| -24% | -$7.74M | 0.05% | 390 |
|
|
2020
Q4 | $34M | Buy |
159,769
+58,475
| +58% | +$11.7M | 0.07% | 289 |
|
|
2020
Q3 | $17.4M | Sell |
101,294
-66,200
| -40% | -$12.2M | 0.04% | 414 |
|
|
2020
Q2 | $32.2M | Sell |
167,494
-96,420
| -37% | -$15.8M | 0.08% | 274 |
|
|
2020
Q1 | $38.9M | Buy |
263,914
+96,324
| +57% | +$15.3M | 0.12% | 214 |
|
|
2019
Q4 | $26M | Sell |
167,590
-7,075
| -4% | -$1.02M | 0.06% | 328 |
|
|
2019
Q3 | $23.6M | Buy |
174,665
+400
| +0.2% | +$52.4K | 0.06% | 330 |
|
|
2019
Q2 | $21.3M | Sell |
174,265
-5,783
| -3% | -$641K | 0.05% | 356 |
|
|
2019
Q1 | $18.7M | Buy |
180,048
+1,893
| +1% | +$195K | 0.05% | 397 |
|
|
2018
Q4 | $20.3M | Sell |
178,155
-3,636
| -2% | -$390K | 0.06% | 325 |
|
|
2018
Q3 | $21M | Sell |
181,791
-5,800
| -3% | -$635K | 0.05% | 388 |
|
|
2018
Q2 | $19.4M | Buy |
187,591
+122,151
| +187% | +$12.4M | 0.04% | 402 |
|
|
2018
Q1 | $6.44M | Buy |
+65,440
| New | +$6.18M | 0.02% | 623 |
|
|
2015
Q3 | – | Sell |
-100,000
| Closed | -$5.64M | – | 747 |
|
|
2015
Q2 | $5.64M | Sell |
100,000
-100,000
| -50% | -$6.31M | 0.01% | 622 |
|
|
2015
Q1 | $14.4M | Buy |
+200,000
| New | +$13M | 0.04% | 486 |
|
Other funds holding RMD
Adage Capital Partners's RMD Position: Q4 2025 in Review
Adage Capital Partners sold out of ResMed (RMD) in Q4 2025, closing a stake of 42,531 shares — an estimated $11.6M sold.
Adage Capital Partners first reported a position in RMD in Q1 2015 and held it in 31 quarters. The position peaked at $42.9M in Q2 2023. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.
- Adage Capital Partners reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
- Adage Capital Partners sold 42,531 ResMed shares in Q4 2025, an estimated $11.6M.
- Adage Capital Partners first reported a position in ResMed in Q1 2015 and held it in 31 quarters.
- Adage Capital Partners's ResMed position peaked at $42.9M in Q2 2023.
- 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.
Based on Adage Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.